BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wei MY, Shi S, Liang C, Meng QC, Hua J, Zhang YY, Liu J, Zhang B, Xu J, Yu XJ. The microbiota and microbiome in pancreatic cancer: more influential than expected. Mol Cancer 2019;18:97. [PMID: 31109338 DOI: 10.1186/s12943-019-1008-0] [Cited by in Crossref: 53] [Cited by in F6Publishing: 89] [Article Influence: 17.7] [Reference Citation Analysis]
Number Citing Articles
1 Mattos VC, Nascimento FSD, Suzuki MO, Taba JV, Pipek LZ, Moraes WAF, Cortez VS, Kubrusly MS, Torsani MB, Iuamoto L, Hsing WT, Carneiro-D'Albuquerque LA, Meyer A, Andraus W. MICRObiota on BILIOpancreatic malignant diseases [MICROBILIO]: A systematic review. Clinics (Sao Paulo) 2022;77:100101. [PMID: 36122499 DOI: 10.1016/j.clinsp.2022.100101] [Reference Citation Analysis]
2 Stanciu S, Ionita-Radu F, Stefani C, Miricescu D, Stanescu-Spinu II, Greabu M, Ripszky Totan A, Jinga M. Targeting PI3K/AKT/mTOR Signaling Pathway in Pancreatic Cancer: From Molecular to Clinical Aspects. Int J Mol Sci 2022;23:10132. [PMID: 36077529 DOI: 10.3390/ijms231710132] [Reference Citation Analysis]
3 Bartolini I, Nannini G, Risaliti M, Matarazzo F, Moraldi L, Ringressi MN, Taddei A, Amedei A. Impact of microbiota-immunity axis in pancreatic cancer management. World J Gastroenterol 2022; 28(32): 4527-4539 [DOI: 10.3748/wjg.v28.i32.4527] [Reference Citation Analysis]
4 Fang Y, Yang G, Yang J, Ren J, You L, Zhao Y. Human microbiota colonization and pancreatic ductal carcinoma. Crit Rev Microbiol 2022;:1-14. [PMID: 35924947 DOI: 10.1080/1040841X.2022.2080526] [Reference Citation Analysis]
5 Lumish MA, Cercek A. Practical Considerations in Diagnosing and Managing Early-Onset GI Cancers. J Clin Oncol 2022;:JCO2102708. [PMID: 35839438 DOI: 10.1200/JCO.21.02708] [Reference Citation Analysis]
6 Park JH, Hong JY, Han K, Kang W, Park JK. Increased risk of pancreatic cancer in individuals with non-alcoholic fatty liver disease. Sci Rep 2022;12:10681. [PMID: 35739172 DOI: 10.1038/s41598-022-14856-w] [Reference Citation Analysis]
7 Li Z, Liu Y, Zhang L. Role of the microbiome in oral cancer occurrence, progression and therapy. Microb Pathog 2022;169:105638. [PMID: 35718272 DOI: 10.1016/j.micpath.2022.105638] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
8 Gupta I, Pedersen S, Vranic S, Al Moustafa AE. Implications of Gut Microbiota in Epithelial-Mesenchymal Transition and Cancer Progression: A Concise Review. Cancers (Basel) 2022;14:2964. [PMID: 35740629 DOI: 10.3390/cancers14122964] [Reference Citation Analysis]
9 Herremans KM, Riner AN, Cameron ME, McKinley KL, Triplett EW, Hughes SJ, Trevino JG. The oral microbiome, pancreatic cancer and human diversity in the age of precision medicine. Microbiome 2022;10:93. [PMID: 35701831 DOI: 10.1186/s40168-022-01262-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
10 Li Y, Wang S, Lin M, Hou C, Li C, Li G. Analysis of interactions of immune checkpoint inhibitors with antibiotics in cancer therapy. Front Med 2022. [PMID: 35648368 DOI: 10.1007/s11684-022-0927-0] [Reference Citation Analysis]
11 Zhao M, Chen X, Yang Z, Yang X, Peng Q. Bacteria and tumor: Understanding the roles of bacteria in tumor genesis and immunology. Microbiol Res 2022;261:127082. [PMID: 35660471 DOI: 10.1016/j.micres.2022.127082] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Xie Y, Xie F, Zhou X, Zhang L, Yang B, Huang J, Wang F, Yan H, Zeng L, Zhang L, Zhou F. Microbiota in Tumors: From Understanding to Application. Adv Sci (Weinh) 2022;:e2200470. [PMID: 35603968 DOI: 10.1002/advs.202200470] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Wang ZW, Pan JJ, Hu JF, Zhang JQ, Huang L, Huang Y, Liao CY, Yang C, Chen ZW, Wang YD, Shen BY, Tian YF, Chen S. SRSF3-mediated regulation of N6-methyladenosine modification-related lncRNA ANRIL splicing promotes resistance of pancreatic cancer to gemcitabine. Cell Rep 2022;39:110813. [PMID: 35545048 DOI: 10.1016/j.celrep.2022.110813] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
14 Zhang Z, Tang D. The huge clinical potential of microbiota in the treatment of pancreatic cancer: The next frontier. Biochim Biophys Acta Rev Cancer 2022;:188733. [PMID: 35483491 DOI: 10.1016/j.bbcan.2022.188733] [Reference Citation Analysis]
15 Cencioni C, Trestini I, Piro G, Bria E, Tortora G, Carbone C, Spallotta F. Gastrointestinal Cancer Patient Nutritional Management: From Specific Needs to Novel Epigenetic Dietary Approaches. Nutrients 2022;14:1542. [DOI: 10.3390/nu14081542] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Yang Q, Zhang J, Zhu Y. Potential Roles of the Gut Microbiota in Pancreatic Carcinogenesis and Therapeutics. Front Cell Infect Microbiol 2022;12:872019. [DOI: 10.3389/fcimb.2022.872019] [Reference Citation Analysis]
17 Kaźmierczak-Siedlecka K, Skonieczna-Żydecka K, Hupp T, Duchnowska R, Marek-Trzonkowska N, Połom K. Next-generation probiotics - do they open new therapeutic strategies for cancer patients? Gut Microbes 2022;14:2035659. [PMID: 35167406 DOI: 10.1080/19490976.2022.2035659] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
18 Lee HA, Chen KW, Hsu CY. Prediction Model for Pancreatic Cancer-A Population-Based Study from NHIRD. Cancers (Basel) 2022;14:882. [PMID: 35205630 DOI: 10.3390/cancers14040882] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 Zhang M, Zhang Y, Sun Y, Wang S, Liang H, Han Y, Abdulhay E. Intratumoral Microbiota Impacts the First-Line Treatment Efficacy and Survival in Non-Small Cell Lung Cancer Patients Free of Lung Infection. Journal of Healthcare Engineering 2022;2022:1-7. [DOI: 10.1155/2022/5466853] [Reference Citation Analysis]
20 Grochowska M, Perlejewski K, Laskus T, Radkowski M. The Role of Gut Microbiota in Gastrointestinal Tract Cancers. Arch Immunol Ther Exp (Warsz) 2022;70:7. [PMID: 35112169 DOI: 10.1007/s00005-021-00641-6] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
21 Huang Y, Zhu N, Zheng X, Liu Y, Lu H, Yin X, Hao H, Tan Y, Wang D, Hu H, Liang Y, Li X, Hu Z, Yin Y. Intratumor Microbiome Analysis Identifies Positive Association Between Megasphaera and Survival of Chinese Patients With Pancreatic Ductal Adenocarcinomas. Front Immunol 2022;13:785422. [DOI: 10.3389/fimmu.2022.785422] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
22 Huët MAL, Lee CZ, Rahman S. A review on association of fungi with the development and progression of carcinogenesis in the human body. Curr Res Microb Sci 2022;3:100090. [PMID: 34917994 DOI: 10.1016/j.crmicr.2021.100090] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
23 Schepis T, De Lucia SS, Nista EC, Manilla V, Pignataro G, Ojetti V, Piccioni A, Gasbarrini A, Franceschi F, Candelli M. Microbiota in Pancreatic Diseases: A Review of the Literature. J Clin Med 2021;10:5920. [PMID: 34945216 DOI: 10.3390/jcm10245920] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
24 Sędzikowska A, Szablewski L. Human Gut Microbiota in Health and Selected Cancers. Int J Mol Sci 2021;22:13440. [PMID: 34948234 DOI: 10.3390/ijms222413440] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
25 Sobocki BK, Kaźmierczak-Siedlecka K, Folwarski M, Hawryłkowicz V, Makarewicz W, Stachowska E. Pancreatic Cancer and Gut Microbiome-Related Aspects: A Comprehensive Review and Dietary Recommendations. Nutrients 2021;13:4425. [PMID: 34959977 DOI: 10.3390/nu13124425] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
26 Panebianco C, Ciardiello D, Villani A, Maiorano BA, Latiano TP, Maiello E, Perri F, Pazienza V. Insights into the role of gut and intratumor microbiota in pancreatic ductal adenocarcinoma as new key players in preventive, diagnostic and therapeutic perspective. Semin Cancer Biol 2021:S1044-579X(21)00280-7. [PMID: 34838957 DOI: 10.1016/j.semcancer.2021.11.007] [Reference Citation Analysis]
27 Zhou H, Yuan Y, Wang H, Xiang W, Li S, Zheng H, Wen Y, Ming Y, Chen L, Zhou J. Gut Microbiota: A Potential Target for Cancer Interventions. Cancer Manag Res 2021;13:8281-96. [PMID: 34764691 DOI: 10.2147/CMAR.S328249] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
28 Liao G, Wu J, Peng X, Li Y, Tang L, Xu X, Deng D, Zhou X. Visualized analysis of trends and hotspots in global oral microbiome research: A bibliometric study. MedComm (2020) 2020;1:351-61. [PMID: 34766127 DOI: 10.1002/mco2.47] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
29 Huang X, Li M, Hou S, Tian B. Role of the microbiome in systemic therapy for pancreatic ductal adenocarcinoma (Review). Int J Oncol 2021;59:101. [PMID: 34738624 DOI: 10.3892/ijo.2021.5281] [Reference Citation Analysis]
30 Higuchi R, Goto T, Hirotsu Y, Otake S, Oyama T, Amemiya K, Ohyama H, Mochizuki H, Omata M. Sphingomonas and Phenylobacterium as Major Microbiota in Thymic Epithelial Tumors. J Pers Med 2021;11:1092. [PMID: 34834444 DOI: 10.3390/jpm11111092] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
31 Schizas D, Koumpoura A, Galari M, Economopoulou P, Vailas M, Sotiropoulou M, Dimitroulis D, Maroulis I, Felekouras E. A personalized approach to pancreatic ductal adenocarcinoma and its application in surgical practice. Per Med 2021;18:613-27. [PMID: 34676789 DOI: 10.2217/pme-2021-0031] [Reference Citation Analysis]
32 Nalluri H, Jensen E, Staley C. Role of biliary stent and neoadjuvant chemotherapy in the pancreatic tumor microbiome. BMC Microbiol 2021;21:280. [PMID: 34656097 DOI: 10.1186/s12866-021-02339-3] [Reference Citation Analysis]
33 Lee K, Oh HJ, Kang MS, Kim S, Ahn S, Kim MJ, Kim SW, Chang S. Metagenomic analysis of gut microbiome reveals a dynamic change in Alistipes onderdonkii in the preclinical model of pancreatic cancer, suppressing its proliferation. Appl Microbiol Biotechnol 2021;105:8343-58. [PMID: 34648062 DOI: 10.1007/s00253-021-11617-z] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
34 Basu M, Philipp LM, Baines JF, Sebens S. The Microbiome Tumor Axis: How the Microbiome Could Contribute to Clonal Heterogeneity and Disease Outcome in Pancreatic Cancer. Front Oncol 2021;11:740606. [PMID: 34631577 DOI: 10.3389/fonc.2021.740606] [Reference Citation Analysis]
35 Krigul KL, Aasmets O, Lüll K, Org T, Org E. Using fecal immunochemical tubes for the analysis of the gut microbiome has the potential to improve colorectal cancer screening. Sci Rep 2021;11:19603. [PMID: 34599256 DOI: 10.1038/s41598-021-99046-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
36 Group Young Researchers In Inflammatory Carcinogenesis, Wandmacher AM, Mehdorn AS, Sebens S. The Heterogeneity of the Tumor Microenvironment as Essential Determinant of Development, Progression and Therapy Response of Pancreatic Cancer. Cancers (Basel) 2021;13:4932. [PMID: 34638420 DOI: 10.3390/cancers13194932] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
37 Trestini I, Carbognin L, Peretti U, Sperduti I, Caldart A, Tregnago D, Avancini A, Auriemma A, Orsi G, Pilotto S, Frulloni L, Capurso G, Bria E, Reni M, Tortora G, Milella M. Pancreatic Enzyme Replacement Therapy in Patients Undergoing First-Line Gemcitabine Plus nab-paclitaxel for Advanced Pancreatic Adenocarcinoma. Front Oncol 2021;11:688889. [PMID: 34568019 DOI: 10.3389/fonc.2021.688889] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
38 An Y, Zhang W, Liu T, Wang B, Cao H. The intratumoural microbiota in cancer: new insights from inside. Biochim Biophys Acta Rev Cancer 2021;1876:188626. [PMID: 34520804 DOI: 10.1016/j.bbcan.2021.188626] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
39 Cortez NE, Mackenzie GG. Ketogenic Diets in Pancreatic Cancer and Associated Cachexia: Cellular Mechanisms and Clinical Perspectives. Nutrients 2021;13:3202. [PMID: 34579079 DOI: 10.3390/nu13093202] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
40 Brandi G, Turroni S, McAllister F, Frega G. The Human Microbiomes in Pancreatic Cancer: Towards Evidence-Based Manipulation Strategies? Int J Mol Sci 2021;22:9914. [PMID: 34576078 DOI: 10.3390/ijms22189914] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
41 Guo W, Zhang Y, Guo S, Mei Z, Liao H, Dong H, Wu K, Ye H, Zhang Y, Zhu Y, Lang J, Hu L, Jin G, Kong X. Tumor microbiome contributes to an aggressive phenotype in the basal-like subtype of pancreatic cancer. Commun Biol 2021;4:1019. [PMID: 34465850 DOI: 10.1038/s42003-021-02557-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
42 Wang J, Wang Y, Li Z, Gao X, Huang D. Global Analysis of Microbiota Signatures in Four Major Types of Gastrointestinal Cancer. Front Oncol 2021;11:685641. [PMID: 34422640 DOI: 10.3389/fonc.2021.685641] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
43 Kaźmierczak-Siedlecka K, Roviello G, Catalano M, Polom K. Gut Microbiota Modulation in the Context of Immune-Related Aspects of Lactobacillus spp. and Bifidobacterium spp. in Gastrointestinal Cancers. Nutrients 2021;13:2674. [PMID: 34444834 DOI: 10.3390/nu13082674] [Cited by in Crossref: 2] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
44 Lee KA, Luong MK, Shaw H, Nathan P, Bataille V, Spector TD. The gut microbiome: what the oncologist ought to know. Br J Cancer 2021. [PMID: 34262150 DOI: 10.1038/s41416-021-01467-x] [Cited by in F6Publishing: 18] [Reference Citation Analysis]
45 Bellotti R, Speth C, Adolph TE, Lass-Flörl C, Effenberger M, Öfner D, Maglione M. Micro- and Mycobiota Dysbiosis in Pancreatic Ductal Adenocarcinoma Development. Cancers (Basel) 2021;13:3431. [PMID: 34298645 DOI: 10.3390/cancers13143431] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
46 Pan LL, Li BB, Pan XH, Sun J. Gut microbiota in pancreatic diseases: possible new therapeutic strategies. Acta Pharmacol Sin 2021;42:1027-39. [PMID: 33093569 DOI: 10.1038/s41401-020-00532-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
47 Lu SY, Hua J, Xu J, Wei MY, Liang C, Meng QC, Liu J, Zhang B, Wang W, Yu XJ, Shi S. Microorganisms in chemotherapy for pancreatic cancer: An overview of current research and future directions. Int J Biol Sci 2021;17:2666-82. [PMID: 34326701 DOI: 10.7150/ijbs.59117] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
48 Bisht V, Acharjee A, Gkoutos GV. NFnetFu: A novel workflow for microbiome data fusion. Comput Biol Med 2021;135:104556. [PMID: 34216888 DOI: 10.1016/j.compbiomed.2021.104556] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
49 Park SY, Hwang BO, Lim M, Ok SH, Lee SK, Chun KS, Park KK, Hu Y, Chung WY, Song NY. Oral-Gut Microbiome Axis in Gastrointestinal Disease and Cancer. Cancers (Basel) 2021;13:2124. [PMID: 33924899 DOI: 10.3390/cancers13092124] [Cited by in F6Publishing: 18] [Reference Citation Analysis]
50 Higuchi R, Goto T, Hirotsu Y, Otake S, Oyama T, Amemiya K, Mochizuki H, Omata M. Streptococcus australis and Ralstonia pickettii as Major Microbiota in Mesotheliomas. J Pers Med 2021;11:297. [PMID: 33919754 DOI: 10.3390/jpm11040297] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
51 LaCourse KD, Johnston CD, Bullman S. The relationship between gastrointestinal cancers and the microbiota. Lancet Gastroenterol Hepatol 2021;6:498-509. [PMID: 33743198 DOI: 10.1016/S2468-1253(20)30362-9] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
52 Kim JR, Han K, Han Y, Kang N, Shin TS, Park HJ, Kim H, Kwon W, Lee S, Kim YK, Park T, Jang JY. Microbiome Markers of Pancreatic Cancer Based on Bacteria-Derived Extracellular Vesicles Acquired from Blood Samples: A Retrospective Propensity Score Matching Analysis. Biology (Basel) 2021;10:219. [PMID: 33805810 DOI: 10.3390/biology10030219] [Cited by in Crossref: 1] [Cited by in F6Publishing: 12] [Article Influence: 1.0] [Reference Citation Analysis]
53 Holbrook MC, Goad DW, Grdzelishvili VZ. Expanding the Spectrum of Pancreatic Cancers Responsive to Vesicular Stomatitis Virus-Based Oncolytic Virotherapy: Challenges and Solutions. Cancers (Basel) 2021;13:1171. [PMID: 33803211 DOI: 10.3390/cancers13051171] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
54 McCoy KD, Mager LF. Impact of the microbiome on tumor immunity. Curr Opin Immunol 2021;69:39-46. [PMID: 33647829 DOI: 10.1016/j.coi.2021.01.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
55 Tijeras-Raballand A, Hilmi M, Astorgues-Xerri L, Nicolle R, Bièche I, Neuzillet C. Microbiome and pancreatic ductal adenocarcinoma. Clin Res Hepatol Gastroenterol 2021;45:101589. [PMID: 33607375 DOI: 10.1016/j.clinre.2020.101589] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
56 Turanli B, Yildirim E, Gulfidan G, Arga KY, Sinha R. Current State of "Omics" Biomarkers in Pancreatic Cancer. J Pers Med 2021;11:127. [PMID: 33672926 DOI: 10.3390/jpm11020127] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
57 Principe DR, Korc M, Kamath SD, Munshi HG, Rana A. Trials and tribulations of pancreatic cancer immunotherapy. Cancer Lett 2021;504:1-14. [PMID: 33549709 DOI: 10.1016/j.canlet.2021.01.031] [Cited by in Crossref: 4] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
58 Wei X, Mei C, Li X, Xie Y. The Unique Microbiome and Immunity in Pancreatic Cancer. Pancreas 2021;50:119-29. [DOI: 10.1097/mpa.0000000000001744] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
59 Zhang W, Zhang K, Zhang P, Zheng J, Min C, Li X. Research Progress of Pancreas-Related Microorganisms and Pancreatic Cancer. Front Oncol 2020;10:604531. [PMID: 33520714 DOI: 10.3389/fonc.2020.604531] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
60 Yang S, Liu Q, Liao Q. Tumor-Associated Macrophages in Pancreatic Ductal Adenocarcinoma: Origin, Polarization, Function, and Reprogramming. Front Cell Dev Biol 2020;8:607209. [PMID: 33505964 DOI: 10.3389/fcell.2020.607209] [Cited by in Crossref: 5] [Cited by in F6Publishing: 39] [Article Influence: 5.0] [Reference Citation Analysis]
61 Li X, Jiang W, Gan Y, Zhou W. The Application of Exosomal MicroRNAs in the Treatment of Pancreatic Cancer and Its Research Progress. Pancreas 2021;50:12-6. [PMID: 33370018 DOI: 10.1097/MPA.0000000000001713] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
62 Zhao Z, Liu W. Pancreatic Cancer: A Review of Risk Factors, Diagnosis, and Treatment. Technol Cancer Res Treat 2020;19:1533033820962117. [PMID: 33357065 DOI: 10.1177/1533033820962117] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 7.0] [Reference Citation Analysis]
63 Wei AL, Li M, Li GQ, Wang X, Hu WM, Li ZL, Yuan J, Liu HY, Zhou LL, Li K, Li A, Fu MR. Oral microbiome and pancreatic cancer. World J Gastroenterol 2020; 26(48): 7679-7692 [PMID: 33505144 DOI: 10.3748/wjg.v26.i48.7679] [Cited by in CrossRef: 20] [Cited by in F6Publishing: 19] [Article Influence: 10.0] [Reference Citation Analysis]
64 Rezasoltani S, Yadegar A, Asadzadeh Aghdaei H, Reza Zali M. Modulatory effects of gut microbiome in cancer immunotherapy: A novel paradigm for blockade of immune checkpoint inhibitors. Cancer Med 2021;10:1141-54. [PMID: 33369247 DOI: 10.1002/cam4.3694] [Cited by in Crossref: 3] [Cited by in F6Publishing: 14] [Article Influence: 1.5] [Reference Citation Analysis]
65 Ciernikova S, Novisedlakova M, Cholujova D, Stevurkova V, Mego M. The Emerging Role of Microbiota and Microbiome in Pancreatic Ductal Adenocarcinoma.Biomedicines. 2020;8. [PMID: 33287196 DOI: 10.3390/biomedicines8120565] [Cited by in Crossref: 3] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
66 Chen SM, Hsu LJ, Lee HL, Lin CP, Huang SW, Lai CJ, Lin CW, Chen WT, Chen YJ, Lin YC, Yang CC, Jan MS. Lactobacillus Attenuate the Progression of Pancreatic Cancer Promoted by Porphyromonas Gingivalis in K-rasG12D Transgenic Mice. Cancers (Basel) 2020;12:E3522. [PMID: 33255941 DOI: 10.3390/cancers12123522] [Cited by in Crossref: 3] [Cited by in F6Publishing: 14] [Article Influence: 1.5] [Reference Citation Analysis]
67 Li P, Shu Y, Gu Y. The potential role of bacteria in pancreatic cancer: a systematic review. Carcinogenesis. 2020;41:397-404. [PMID: 32034405 DOI: 10.1093/carcin/bgaa013] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
68 Li Q, Jin M, Liu Y, Jin L. Gut Microbiota: Its Potential Roles in Pancreatic Cancer. Front Cell Infect Microbiol. 2020;10:572492. [PMID: 33117731 DOI: 10.3389/fcimb.2020.572492] [Cited by in Crossref: 6] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
69 Chakladar J, Kuo SZ, Castaneda G, Li WT, Gnanasekar A, Yu MA, Chang EY, Wang XQ, Ongkeko WM. The Pancreatic Microbiome is Associated with Carcinogenesis and Worse Prognosis in Males and Smokers.Cancers (Basel). 2020;12. [PMID: 32962112 DOI: 10.3390/cancers12092672] [Cited by in Crossref: 5] [Cited by in F6Publishing: 14] [Article Influence: 2.5] [Reference Citation Analysis]
70 Langheinrich M, Wirtz S, Kneis B, Gittler MM, Tyc O, Schierwagen R, Brunner M, Krautz C, Weber GF, Pilarsky C, Trebicka J, Agaimy A, Grützmann R, Kersting S. Microbiome Patterns in Matched Bile, Duodenal, Pancreatic Tumor Tissue, Drainage, and Stool Samples: Association with Preoperative Stenting and Postoperative Pancreatic Fistula Development. J Clin Med 2020;9:E2785. [PMID: 32872220 DOI: 10.3390/jcm9092785] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
71 Wang Z, Liu T, Xue W, Fang Y, Chen X, Xu L, Zhang L, Guan K, Pan J, Zheng L, Qin G, Wang T. ARNTL2 promotes pancreatic ductal adenocarcinoma progression through TGF/BETA pathway and is regulated by miR-26a-5p. Cell Death Dis 2020;11:692. [PMID: 32826856 DOI: 10.1038/s41419-020-02839-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
72 Tiffon C. Defining Parallels between the Salivary Glands and Pancreas to Better Understand Pancreatic Carcinogenesis. Biomedicines 2020;8:E178. [PMID: 32604970 DOI: 10.3390/biomedicines8060178] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
73 Sanchez P, Espinosa M, Maldonado V, Barquera R, Belem-Gabiño N, Torres J, Cravioto A, Melendez-Zajgla J. Pancreatic ductal adenocarcinomas from Mexican patients present a distinct genomic mutational pattern. Mol Biol Rep 2020;47:5175-84. [PMID: 32583281 DOI: 10.1007/s11033-020-05592-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
74 Song X, Wang X, Hu Y, Li H, Ren T, Li Y, Liu L, Li L, Li X, Wang Z, Huang W, Bao R, Zhang Y, Li M, Wang X, Liu F, Gu J, Zheng L, Wu W, Liu Y. A metagenomic study of biliary microbiome change along the cholecystitis-carcinoma sequence. Clin Transl Med 2020;10:e97. [PMID: 32526082 DOI: 10.1002/ctm2.97] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
75 Manzoor SS, Doedens A, Burns MB. The promise and challenge of cancer microbiome research. Genome Biol 2020;21:131. [PMID: 32487228 DOI: 10.1186/s13059-020-02037-9] [Cited by in Crossref: 8] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
76 Zubair H, Khan MA, Anand S, Srivastava SK, Singh S, Singh AP. Modulation of the tumor microenvironment by natural agents: implications for cancer prevention and therapy. Semin Cancer Biol 2020:S1044-579X(20)30105-X. [PMID: 32470379 DOI: 10.1016/j.semcancer.2020.05.009] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 5.5] [Reference Citation Analysis]
77 Kaźmierczak-Siedlecka K, Dvořák A, Folwarski M, Daca A, Przewłócka K, Makarewicz W. Fungal Gut Microbiota Dysbiosis and Its Role in Colorectal, Oral, and Pancreatic Carcinogenesis. Cancers (Basel) 2020;12:E1326. [PMID: 32455985 DOI: 10.3390/cancers12051326] [Cited by in Crossref: 10] [Cited by in F6Publishing: 22] [Article Influence: 5.0] [Reference Citation Analysis]
78 Luo W, Cao Z, Qiu J, Liu Y, Zheng L, Zhang T. Novel Discoveries Targeting Pathogenic Gut Microbes and New Therapies in Pancreatic Cancer: Does Pathogenic E. coli Infection Cause Pancreatic Cancer Progression Modulated by TUBB/Rho/ROCK Signaling Pathway? A Bioinformatic Analysis. Biomed Res Int 2020;2020:2340124. [PMID: 32461969 DOI: 10.1155/2020/2340124] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
79 Principe DR, Rana A. Updated risk factors to inform early pancreatic cancer screening and identify high risk patients. Cancer Lett 2020;485:56-65. [PMID: 32389710 DOI: 10.1016/j.canlet.2020.04.022] [Cited by in Crossref: 4] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
80 Elsalem L, Jum'ah AA, Alfaqih MA, Aloudat O. The Bacterial Microbiota of Gastrointestinal Cancers: Role in Cancer Pathogenesis and Therapeutic Perspectives. Clin Exp Gastroenterol 2020;13:151-85. [PMID: 32440192 DOI: 10.2147/CEG.S243337] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 6.5] [Reference Citation Analysis]
81 Kiss B, Mikó E, Sebő É, Toth J, Ujlaki G, Szabó J, Uray K, Bai P, Árkosy P. Oncobiosis and Microbial Metabolite Signaling in Pancreatic Adenocarcinoma. Cancers (Basel) 2020;12:E1068. [PMID: 32344895 DOI: 10.3390/cancers12051068] [Cited by in Crossref: 9] [Cited by in F6Publishing: 15] [Article Influence: 4.5] [Reference Citation Analysis]
82 Li H, Chen M, Yang Z, Wang Q, Wang J, Jin D, Yang X, Chen F, Zhou X, Luo K. Phillygenin, a MELK Inhibitor, Inhibits Cell Survival and Epithelial-Mesenchymal Transition in Pancreatic Cancer Cells. Onco Targets Ther 2020;13:2833-42. [PMID: 32308417 DOI: 10.2147/OTT.S238958] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
83 Sollie S, Santaolalla A, Michaud DS, Sarker D, Karagiannis SN, Josephs DH, Hammar N, Walldius G, Garmo H, Holmberg L, Jungner I, Van Hemelrijck M. Serum Immunoglobulin G Is Associated With Decreased Risk of Pancreatic Cancer in the Swedish AMORIS Study. Front Oncol 2020;10:263. [PMID: 32185133 DOI: 10.3389/fonc.2020.00263] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
84 Søreide K, Roalsø M, Aunan JR. Is There a Trojan Horse to Aggressive Pancreatic Cancer Biology? A Review of the Trypsin-PAR2 Axis to Proliferation, Early Invasion, and Metastasis. J Pancreat Cancer 2020;6:12-20. [PMID: 32064449 DOI: 10.1089/pancan.2019.0014] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
85 Li K, Ma C, Li H, Dev S, He J, Qu X. Medicinal Value and Potential Therapeutic Mechanisms of Gynostemma pentaphyllum (Thunb.) Makino and Its Derivatives: An Overview. CTMC 2020;19:2855-67. [DOI: 10.2174/1568026619666191114104718] [Cited by in Crossref: 5] [Cited by in F6Publishing: 13] [Article Influence: 2.5] [Reference Citation Analysis]
86 Liu X, Xu J, Zhang B, Liu J, Liang C, Meng Q, Hua J, Yu X, Shi S. The reciprocal regulation between host tissue and immune cells in pancreatic ductal adenocarcinoma: new insights and therapeutic implications. Mol Cancer 2019;18:184. [PMID: 31831007 DOI: 10.1186/s12943-019-1117-9] [Cited by in Crossref: 18] [Cited by in F6Publishing: 29] [Article Influence: 6.0] [Reference Citation Analysis]
87 Sun Z, Xiong C, Teh SW, Lim JCW, Kumar S, Thilakavathy K. Mechanisms of Oral Bacterial Virulence Factors in Pancreatic Cancer. Front Cell Infect Microbiol 2019;9:412. [PMID: 31867287 DOI: 10.3389/fcimb.2019.00412] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
88 Wang Y, Yang G, You L, Yang J, Feng M, Qiu J, Zhao F, Liu Y, Cao Z, Zheng L, Zhang T, Zhao Y. Role of the microbiome in occurrence, development and treatment of pancreatic cancer. Mol Cancer. 2019;18:173. [PMID: 31785619 DOI: 10.1186/s12943-019-1103-2] [Cited by in Crossref: 14] [Cited by in F6Publishing: 25] [Article Influence: 4.7] [Reference Citation Analysis]
89 Paternoster S, Falasca M. The intricate relationship between diabetes, obesity and pancreatic cancer. Biochim Biophys Acta Rev Cancer. 2020;1873:188326. [PMID: 31707038 DOI: 10.1016/j.bbcan.2019.188326] [Cited by in Crossref: 19] [Cited by in F6Publishing: 22] [Article Influence: 6.3] [Reference Citation Analysis]
90 Vitiello GA, Cohen DJ, Miller G. Harnessing the Microbiome for Pancreatic Cancer Immunotherapy. Trends in Cancer 2019;5:670-6. [DOI: 10.1016/j.trecan.2019.10.005] [Cited by in Crossref: 11] [Cited by in F6Publishing: 17] [Article Influence: 3.7] [Reference Citation Analysis]
91 Zhang Z, Tang H, Chen P, Xie H, Tao Y. Demystifying the manipulation of host immunity, metabolism, and extraintestinal tumors by the gut microbiome. Signal Transduct Target Ther 2019;4:41. [PMID: 31637019 DOI: 10.1038/s41392-019-0074-5] [Cited by in Crossref: 53] [Cited by in F6Publishing: 88] [Article Influence: 17.7] [Reference Citation Analysis]